Medical Marijuana, Inc. and Subsidiaries HempMeds®, HempMeds® Mexico, HempMeds® Brasil and Kannaway® Announce 2018 as the Largest Sales Booking Year in Company History

Medical Marijuana, Inc. and Subsidiaries HempMeds®, HempMeds® Mexico, HempMeds® Brasil and Kannaway® Announce 2018 as the Largest Sales Booking Year in Company History

SAN DIEGO, Jan. 9, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company and its subsidiaries Kannaway®, HempMeds® Mexico and HempMeds® Brasil generated the largest-ever...
U.S. News & World Report, The Guardian, and More Feature Medical Marijuana, Inc. Portfolio Companies This Week

U.S. News & World Report, The Guardian, and More Feature Medical Marijuana, Inc. Portfolio Companies This Week

Hemp legalization, CBD for pets, and medical marijuana in Latin American lead Medical Marijuana, Inc.’s headlines in this week’s news. Medical Marijuana, Inc.’s global efforts to expand access to CBD and promote its benefits to a worldwide audience was once again on...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Premier Sponsor of CannX Brazil Conference; HempMeds® Mexico President Invited as Featured Speaker

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Premier Sponsor of CannX Brazil Conference; HempMeds® Mexico President Invited as Featured Speaker

SAN DIEGO, Nov. 13, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® Brasil will be a premier sponsor at the CannX Brazil Conference in São Paulo on Nov....